Author

J. B. Finlay

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Immunology· 1 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Research Focus:cell type annotation· 2 Approach:experimental assay· 2 Organism:human· 2 Research Focus:cell-cell communication· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:machine learning (classical)· 1

Frequent Co-Authors

A. M. Hoyt-Miggelbrink· 1 shared B. Goldstein· 1 shared D. Jang· 1 shared D. S. Wilkinson· 1 shared E. A. Bloom-Saldana· 1 shared E. C. Lerner· 1 shared J. Waibl Polania· 1 shared K. Ayasoufi· 1 shared

Activity by Year

2022-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 22 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

A. M. Hoyt-Miggelbrink

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Antigen presentation by tumor-associated macrophages drives tumor-infiltrating T cells from a progenitor exhaustion state to terminal exhaustion

J. Waibl Polania, A. M. Hoyt-Miggelbrink, W. H. Tomaszewski, L. P. Wachsmuth, S. J. Lorrey, D. S. Wilkinson, E. C. Lerner, K. Woroniecka, J. B. Finlay, K. Ayasoufi, P. E. Fecci

The paper identifies tumor-associated macrophages as key drivers of T cell exhaustion transition, showing their role in shifting progenitor exhausted T cells to terminal exhaustion and impacting immunotherapy response.

bioRxiv · Aug 11, 2023 · PreprintImmunology

Deconstructing olfactory epithelium developmental pathways in esthesioneuroblastoma

J. B. Finlay, R. Abi Hachem, D. Jang, N. Osazuwa-Peters, B. Goldstein

This study uses bulk and single-cell RNA-sequencing to analyze ENB tumor samples and identifies cell-type changes and prognostic markers associated with tumor grade.

bioRxiv · Oct 18, 2022 · PreprintCancer Biology

Pharmacokinetics of Sustained-Release Buprenorphine and Extended-Release Buprenorphine in Mice with Surgical Catheterization

M. Saenz, E. A. Bloom-Saldana, T. Synold, R. W. Ermel, P. T. Fueger, J. B. Finlay

This study compares the pharmacokinetics and therapeutic efficacy of sustained-release and extended-release buprenorphine in surgically catheterized mice, showing both maintain therapeutic concentrations for 72 hours.

bioRxiv · Mar 14, 2022Pharmacology & Toxicology